Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Calvez

Showing results (51-60 of 375) with videos related to

Pageof 38
Sort By:
Antimicrobial Agents and Chemotherapy|April 6, 2011
Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropismAdrien Saliou, Pierre Delobel, Martine Dubois, et al.
The European Physical Journal. E, Soft Matter|September 15, 2024
Surface conversion of the dynamics of bacteria escaping chemorepellentsAsma Braham, Laurence Lemelle, Romain Ducasse, et al.
The Journal of Antimicrobial Chemotherapy|November 22, 2014
G118R and F121Y mutations identified in patients failing raltegravir treatment confer dolutegravir resistanceSoundasse Munir, Eloise Thierry, Isabelle Malet, et al.
AIDS (London, England)|December 4, 2002
Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infectionCécile Chouquet, Brigitte Autran, Elisabeth Gomard, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2020
Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patientsAnne-Geneviève Marcelin, Charlotte Charpentier, Aude Jary, et al.
Microbiology Spectrum|June 9, 2025
An amplicon-based approach for full-genome characterization of HPV16Isabelle Malet, Inès Draa, Valentin Leducq, et al.
The Journal of Antimicrobial Chemotherapy|October 22, 2024
Emergent resistance-associated mutations at first- or second-line HIV-1 virologic failure with second-generation InSTIs in two- and three-drug regimens: the Virostar-1 studyAnne-Geneviève Marcelin, Cathia Soulie, Marc Wirden, et al.
Mbio|September 28, 2017
Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer InhibitorsIsabelle Malet, Frédéric Subra, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy|November 16, 2019
Variability of the HIV-1 3' polypurine tract (3'PPT) region and implication in integrase inhibitor resistanceIsabelle Malet, Olivier Delelis, Thuy Nguyen, et al.
The Journal of Infection|May 22, 2014
The multifactorial pathways towards resistance to the cytosine analogues emtricitabine and lamivudine: evidences from literatureValentina Svicher, Claudia Alteri, Maria Mercedes Santoro, et al.
Pageof 38

Showing results (51-60 of 375) with videos related to

Sort By:
Pageof 38
Antimicrobial Agents and Chemotherapy|April 6, 2011
Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropismAdrien Saliou, Pierre Delobel, Martine Dubois, et al.
The European Physical Journal. E, Soft Matter|September 15, 2024
Surface conversion of the dynamics of bacteria escaping chemorepellentsAsma Braham, Laurence Lemelle, Romain Ducasse, et al.
The Journal of Antimicrobial Chemotherapy|November 22, 2014
G118R and F121Y mutations identified in patients failing raltegravir treatment confer dolutegravir resistanceSoundasse Munir, Eloise Thierry, Isabelle Malet, et al.
AIDS (London, England)|December 4, 2002
Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infectionCécile Chouquet, Brigitte Autran, Elisabeth Gomard, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2020
Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patientsAnne-Geneviève Marcelin, Charlotte Charpentier, Aude Jary, et al.
Microbiology Spectrum|June 9, 2025
An amplicon-based approach for full-genome characterization of HPV16Isabelle Malet, Inès Draa, Valentin Leducq, et al.
The Journal of Antimicrobial Chemotherapy|October 22, 2024
Emergent resistance-associated mutations at first- or second-line HIV-1 virologic failure with second-generation InSTIs in two- and three-drug regimens: the Virostar-1 studyAnne-Geneviève Marcelin, Cathia Soulie, Marc Wirden, et al.
Mbio|September 28, 2017
Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer InhibitorsIsabelle Malet, Frédéric Subra, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy|November 16, 2019
Variability of the HIV-1 3' polypurine tract (3'PPT) region and implication in integrase inhibitor resistanceIsabelle Malet, Olivier Delelis, Thuy Nguyen, et al.
The Journal of Infection|May 22, 2014
The multifactorial pathways towards resistance to the cytosine analogues emtricitabine and lamivudine: evidences from literatureValentina Svicher, Claudia Alteri, Maria Mercedes Santoro, et al.
Pageof 38